Items where Author is "Nietlispach, F."

2015

Vontobel, J. and Possner, M. and Schutz, P. and Muller, B. and Taramasso, M. and Binder, R. K. and Haueis, S. and Attinger-Toller, A. and Maisano, F. and Nietlispach, F.. (2015) Early safety outcome following transcatheter aortic valve implantation: is the amount of contrast media used a matter of concern? Swiss Medical Weekly, 145. w14238.

Csordas, A. and Nietlispach, F. and Schuetz, P. and Huber, A. and Muller, B. and Maisano, F. and Taramasso, M. and Moarof, I. and Obeid, S. and Stahli, B. E. and Cahenzly, M. and Binder, R. K. and Liebetrau, C. and Mollmann, H. and Kim, W. K. and Hamm, C. and Luscher, T. F.. (2015) Midregional Proadrenomedullin Improves Risk Stratification beyond Surgical Risk Scores in Patients Undergoing Transcatheter Aortic Valve Replacement. PLoS ONE, 10 (12). e0143761.

2010

Kuster, G. M. and Nietlispach, F. and Kiowski, W. and Schindler, R. and Bernheim, A. and Schuetz, P. and Mueller, B. and Morgenthaler, N. G. and Rüter, F. and Riesen, W. and Rickli, H. and Brunner-La Rocca, H. P.. (2010) Role of RAS inhibition in the regulation of Cu/Zn-SOD in the cardiac and peripheral arterial beds in humans. Clinical Pharmacology and Therapeutics, 87 (6). pp. 686-692.

2009

Pfisterer, M. and Brunner-La Rocca, H. P. and Rickenbacher, P. and Hunziker, P. and Mueller, C. and Nietlispach, F. and Leibundgut, G. and Bader, F. and Kaiser, C. and Basket, . (2009) Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice : does stent diameter matter? Three-year follow-up of BASKET. European heart journal : the journal of the European Society of Cardiology, Vol. 30. pp. 16-24.

2008

Pfisterer, M. and Zellweger, M. J. and Filipovic, M. and Nietlispach, F.. (2008) Antiplatelet therapy : what to do if the patient with a drug-eluting stent needs elective noncardiac surgery? Dialogues in cardiovascular medicine, Vol. 13. pp. 262-266.